Fatty acid-genotype interactions and cardiovascular risk.
Cardiovascular disease (CVD) risk and rate of progression is determined by genetic, environmental and behavioural factors. Majority of genotype-diet-CVD phenotype research till date has focussed on the interactive impact of single nucleotide polymorphisms (SNP) and dietary fat composition, on blood lipids levels, with strong evidence of the existence of hypo- and hyper-responders. However, a recognised concern in the field of nutrigenetics is a lack of consistency between findings of different studies. This apparent lack of consistency is likely to be attributable to the impact of factors such as ethnicity and gender on the 'size' of nutrigenetic interactions, a clear understanding of which needs to be gained. Although not yet ready for widespread use, in the future a greater use of genetic profiling is likely to enhance current strategies of CVD prediction, and improve the design of more personalised approaches to minimise risk in the individual.
Minihane
Anne M
AM
Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. a.m.minihane@reading.ac.uk
D000818:Animals; D002318:Cardiovascular Diseases / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D004041:Dietary Fats / Q000008:administration & dosage; D005227:Fatty Acids / Q000008:administration & dosage / Q000378:metabolism*; D005838:Genotype; D006801:Humans; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D018570:Risk Assessment; D012307:Risk Factors
D004041:Dietary Fats; D005227:Fatty Acids